{
  "trial_id": "NCT01179334",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "18 to 75 years of age at Visit 1",
      "label": "met"
    },
    {
      "criterion": "Male and female subjects with symptomatic PAH (Group I Dana Point Updated Clinical Classification 2008)",
      "label": "unknown"
    },
    {
      "criterion": "Subjects on stable pretreatment with sildenafil at a dose of 20 mg",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "Subject's participating in another clinical trial or who have done so within 30 days before Visit 1",
      "label": "unknown"
    },
    {
      "criterion": "Pregnant women",
      "label": "not_met"
    }
  ],
  "notes": "Patient has severe dyspneic symptomology preventing outpatient living, but is on stable pretreatment with sildenafil at a dose of 20 mg.",
  "_meta": {
    "topic_id": "16",
    "trial_id": "NCT01179334",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}